<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Manag Care Spec Pharm</journal-id><journal-id journal-id-type="iso-abbrev">J Manag Care Spec Pharm</journal-id><journal-id journal-id-type="pmc-domain-id">4474</journal-id><journal-id journal-id-type="pmc-domain">jmcsp</journal-id><journal-id journal-id-type="publisher-id">jmcsp</journal-id><journal-title-group><journal-title>Journal of Managed Care &amp; Specialty Pharmacy</journal-title></journal-title-group><issn pub-type="ppub">2376-0540</issn><issn pub-type="epub">2376-1032</issn><publisher><publisher-name>Academy of Managed Care Pharmacy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10398112</article-id><article-id pub-id-type="pmcid-ver">PMC10398112.1</article-id><article-id pub-id-type="pmcaid">10398112</article-id><article-id pub-id-type="pmcaiid">10398112</article-id><article-id pub-id-type="pmid">31134864</article-id><article-id pub-id-type="doi">10.18553/jmcp.2019.25.6.630</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Perspectives on Value</subject></subj-group></article-categories><title-group><article-title>Effectiveness and Value of Extended-Release Opioid Agonists and Antagonists for Addiction Treatment of Opioid Use Disorder</article-title><subtitle>A Summary from the Institute for Clinical and Economic Review&#8217;s New England Comparative Effectiveness Public Advisory Council</subtitle></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Otuonye</surname><given-names initials="IS">Ifeoma S.</given-names></name><degrees>MPH</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Banken</surname><given-names initials="R">Reiner</given-names></name><degrees>MD, MSc</degrees><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kumar</surname><given-names initials="VM">Varun M.</given-names></name><degrees>MPH, MSc</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pearson</surname><given-names initials="SD">Steven D.</given-names></name><degrees>MD, MSc</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><aff id="aff1"><label><sup>1</sup></label>Institute for Clinical and Economic Review, Boston, Massachusetts.</aff><aff id="aff2"><label><sup>2</sup></label>Direction de sant&#233; publique, CISSS de Laval, Qu&#233;bec, Canada.</aff></contrib-group><author-notes><corresp id="cor1"><label><sup>*</sup></label>AUTHOR CORRESPONDENCE: Ifeoma S. Otuonye, MPH, Institute for Clinical &amp; Economic Review, Two Liberty Square, 9th Fl., Boston, MA 02109. E-mail: <email>iotuonye@icer-review.org</email>.</corresp><fn fn-type="COI-statement"><p>Funding for this summary was contributed by the Laura and John Arnold Foundation, Blue Shield of California, and California Health Care Foundation to the Institute for Clinical and Economic Review (ICER), an independent organization that evaluates the evidence on the value of health care interventions. ICER&#8217;s annual policy summit is supported by dues from Aetna, AHIP Anthem, Blue Shield of California, CVS Caremark, Express Scripts, Harvard Pilgrim Health Care, Cambia Health Solutions, United Healthcare, Kaiser Permanente, Premera Blue Cross, AstraZeneca, Genentech, GlaxoSmithKline, Johnson &amp; Johnson, Merck, National Pharmaceutical Council, Prime Therapeutics, Sanofi, Spark Therapeutics, Health Care Service Corporation, Editas, Alnylam, Regeneron, Mallinkrodt, Biogen, HealthPartners, and Novartis. Otuonye, Kumar, and Pearson are ICER employees. Banken received consulting fees from ICER for work on this report.</p></fn></author-notes><pub-date pub-type="ppub"><month>6</month><year>2019</year></pub-date><volume>25</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">442347</issue-id><elocation-id>10.18553/jmcp.2019.25.6.630</elocation-id><pub-history><event event-type="pmc-release"><date><day>01</day><month>06</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>04</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-02 20:25:14.500"><day>02</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2019, Academy of Managed Care Pharmacy. All rights reserved.</copyright-statement><copyright-year>2019</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jmcp-025-06-630.pdf"/><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>